Webcasts

BioProcess Insider State of the Industry — December 2022 Panel Discussion

This panel discussion features: Christopher Peterson, Associate Director, Latham Biopharm Group; Jason Slingsby, Chief Business & Corporate Development Officer, Oxford Biomedica; Dr. Ger Brophy, Executive Vice President of Biopharma Production, Avantor. BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends. With a panel of industry experts, editor Dan Stanton will discuss recent M&A in the bioprocess space, bottlenecks within the manufacturing sector,…

Lonza: ‘Get CGT processes correct early to avoid late-phase pitfalls’

Lonza says its expertise in the cell and gene therapy space can help sponsors quickly bring products into the clinic and towards commercialization. Contract development and manufacturing organization (CDMO) Lonza is a major player in the advanced therapy space, with facilities in Geleen, The Netherlands and Houston, Texas – the latter described by the firm as the world’s largest dedicated cell and gene therapy manufacturing plant. Speaking at the Cell and Gene Manufacturing and Commercialization (CGMC) Conference in Amsterdam, The…

Polyplus adds plasmid DNA CDMO Xpress Bio to upstream toolbox

Polyplus tells us how such additions as plasmid DNA maker Xpress Biologics bolsters its upstream offering and can help reduce the costs of cell and gene therapies. The deal sees cell and gene therapy upstream solutions firm Polyplus add Belgian contract development and manufacturing organization (CDMO). Financials have not been disclosed, but the acquisition brings plasmid DNA and protein production using microbial expression systems to Polyplus’ engineering technology and services portfolio and will bolster the firm’s ambition to improve gene-therapy…

Video news: Tosoh launches multi-column chromatography tech at CPhI

Tosoh Bioscience says its Octave BIO multi-column chromatography (MCC) system combined with its SkillPak BIO prepacked columns allows customers to efficiently develop preclinical processes. Tosoh showcased the downstream chromatography offering at BioProduction, part of CPhI Frankfurt, this week. “[The Octave Bio system] that we just launched is unique because it can run any type of chromatography processes such as MCC, SMB, intensified batch,” said Romain Dabre, senior manager, Global Product Management, at Tosoh Bioscience. “And you can even do your…

BioProcess Insider State of the Industry – Live from Biotech Week Boston

Ukraine escalation, COVID drop off, cell and gene approvals, and sustainability efforts were the focus of the latest BioProcess Insider State of the Industry discussion at BPI Boston Frank Orlowski, Director of Business Development at Latham Biopharm Group, Miriam Monge, Head of Marketing Fluid Management Technologies at Sartorius, and Joseph Scott, Vice President, Supply Chain at Avid Bioservices, sat down with BioProcess Insider’s Dan Stanton to discuss the geopolitical issues affecting the biomanufacturing space. In front of a full crowd…

Testing times: WuXi ATU investments ready to support CGT cascade

WuXi Advanced Therapies has highlighted its expanded cell and gene therapy testing capabilities in preparation for as many as 200 products reaching the market in the next seven years. “Just 18 months ago there was a little over 1,100 compounds in development. Now there are over 2,000,” Michael Stump, executive director of Testing Operations at WuXi Advanced Therapies said at Biotech Week Boston. “Even a 5-10% success rate, we’re looking at 200 modalities coming into the market in the next…

Star-spangled Gamma looks to disrupt the bioprocess space

Gamma Biosciences presented its portfolio of tech companies at Biotech Week Boston and spoke about its role as a disruptor in the consolidated bioprocess sector. “Gamma was built on this notion that advanced therapy manufacturing to date has largely been served by the biologics industry; the technologies that have been brute forced into our industry to make things work and get products to market,” Gamma Biosciences’ CTO Phil Vanek told BioProcess Insider at BPI East – part of Biotech Week…

Sartorius showcases freezing, filling, and mAb capturing tech

Bioprocess giant Sartorius launched four products at Biotech Week Boston in September 2022. Miriam Monge, head of Marketing Fluid Management Technologies, walks us through them. First on display on the floor of the Boston Convention and Exhibition Center was Sartorius’ Celsius FFT, a large-volume bulk drug substance storage and transport system. According to Monge, such an offering is unique in its scale, and as a full platform, consisting of a blast freezer, a fill and drain station, a lift, a…

Miltenyi looks to offer ‘top-to-bottom’ services as tech meets CDMO

Miltenyi Biotec says it is uniquely placed in the advanced therapy space to support developers with the full gamut of technologies and chemical/biological substances. Founded in 1989, Miltenyi has moved from a cell separation firm into a full cell and gene services firm, offering a host of services including as a contract development and manufacturing organization (CDMO). “What makes Miltenyi unique is we not only supply the expertise from both the technological, biological and even regulatory expertise, but we have…